JPRN-UMIN000004990已完成1 期
Clinical study for PET microdose method by oral dose of [11C]Telmisartan in healthy volunteers - Pharmacokinetics of [11C]Telmisartan by oral dose in healthy volunteers (TEL-2)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 45years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Renal artery stenosis, bilaterally or unilaterally after nephrectomy 2. Hyperkalemia 3. Liver or renal dysfunction 4. Cerebrovascular disorders 5. Hypotension 6. Severe bradycardia, or WPW or LGL syndrome by ECG 7. Medication or dietary supplement including St. John's wort within 7 days prior to PET study
研究者
相似试验
招募中
不适用
Microdosing cinical studies -Assesment of oral bioavailability of drugs by cassete IV and PO dosinghypertension, arrhythmiaJPRN-UMIN000002578Oita university hospital,Clinical pharmacology center8
已完成
不适用
Clinical study to elucidate the efficacy of oral propranolol treatment for infantile hemangiomasInfantile hemangiomasJPRN-UMIN000012123Juntendo University School of Medicine150
已完成
3 期
Efficacy and safety of pentoxifylline in treatment and recovery of patients with COVID-19IRCT20170809035597N2Iran University of Medical Sciences150
已完成
1 期
A Single Microdose Study to Evaluate the Pharmacokinetics of INS018_055 in Healthy ParticipantsACTRN12621001541897Insilico Medicine Hong Kong Limited8
已完成
2 期
Phase IIa examination of the effect of oral dosing of NV-52 on surrogate markers of inflammatory bowel disease (IBD) in patients with stable disease but with a consistent abnormality in one or more surrogate marker.ACTRN12607000617460ovogen Research Pty Ltd10